Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v4-EN
Language French English
Date Updated 2023-11-06 2023-10-26
Drug Identification Number 02306085 02306085
Brand name VALCYTE VALCYTE
Common or Proper name Valganciclovir Powder for Oral Solution Valganciclovir Powder for Oral Solution
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients VALGANCICLOVIR VALGANCICLOVIR
Strength(s) 50MG 50MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 5 g valganciclovir / bottle 5 g valganciclovir / bottle
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-02 2023-05-02
Estimated end date 2023-11-30 2023-11-30
Actual end date 2023-11-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments